SCHEMBL14022883

SCHEMBL14022883

CC(C)COc1ccccc1-c1cc(C2CC=C(c3ccccc3Cl)O2)[nH]c(=O)n1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GCGR P47871 1/20 0.37
MAPK14 Q16539 1/20 0.37
PDE5A O76074 2/20 0.36
PDE4A P27815 1/20 0.36
PDE4B Q07343 1/20 0.36
PDE4C Q08493 1/20 0.36
PDE4D Q08499 1/20 0.36
MGLL Q99685 1/20 0.35
CHRNA7 P36544 1/20 0.35
TBXA2R P21731 1/20 0.35
PTGER1 P34995 1/20 0.35
PPARG P37231 1/20 0.35
PTGER3 P43115 1/20 0.35
F2 P00734 1/20 0.35
F10 P00742 1/20 0.35
PLG P00747 1/20 0.35
PLAU P00749 1/20 0.35
PLAT P00750 1/20 0.35
PIM1 P11309 2/20 0.34
FABP3 P05413 3/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3340238 0.75 PIM1 (0.43) GCGRMAPK14PDE5APDE4APDE4B
SCHEMBL14023023 0.66 PDE5A (0.37) GCGRMAPK14PDE5APDE4APDE4B
SCHEMBL3338542 0.65 KDM4E (0.41) GCGRMAPK14PDE5APDE4APDE4B
SCHEMBL3342615 0.63 TP53 (0.43) GCGRMAPK14PDE5APDE4APDE4B
SCHEMBL3340787 0.63 PDE5A (0.40) GCGRMAPK14PDE5APDE4APDE4B
SCHEMBL14023022 0.62 PIM1 (0.55) GCGRMAPK14PDE5APDE4APDE4B
SCHEMBL386224 0.60 PIM1 (0.67) GCGRMAPK14PDE5APDE4APDE4B
SCHEMBL19039959 0.60 SIRT1 (0.47) MGLLPTGER1ELANE
SCHEMBL15094850 0.60 ADRB2 (0.55) PDE5APDE4APDE4BPDE4CPDE4D
SCHEMBL10314842 0.60 MEN1 (0.51) HTR2CSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008143759-A1 PYRIMIDINONES AS CASEIN KINASE II (CK2) MODULATORS EXELIXIS, INC. (US) 2008-11-27 WO disclosed